Skip to main content
. 2019 Oct 7;77(2). doi: 10.1001/jamaneurol.2019.3365

Figure. Survival Plot for the Time to the First Serious Infection.

Figure.

Product-limit survival estimates of the proportion with no serious infection and number of patients remaining at risk by year since treatment start, for each treatment group. Shaded areas are 95% Hall-Wellner confidence intervals. General population indicates age-matched and sex-matched general population comparator participants who were free of multiple sclerosis. GA indicates glatiramer acetate.